Coya Therapeutics, Inc. (NASDAQ: COYA), a clinical-stage biotechnology company, will participate in the BTIG Virtual Biotechnology Conference on July 29-30, 2025. The company focuses on developing biologics to enhance regulatory T cell function. Attendees interested in learning more or scheduling a meeting with Coya's management can contact their BTIG representative.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Coya Therapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250722618751) on July 22, 2025, and is solely responsible for the information contained therein.